Browsing: Oligometastatic

Several trials have evaluated metastasis directed therapy for oligometastatic prostate cancer, however most have been limited in size. WOLVERINE was…

Headline: Does metastasis directed therapy (MDT) benefit all oligometastatic cancers or does histology call the shots?The Study: EXTEND was a…

Top Line: A slam dunk indication for SBRT is prolonging survival and time to systemic therapy for oligometastatic prostate cancer.The…

Top Line: Can SABR be used to defer chemotherapy in patients with oligometastatic head and neck cancer?The Study: OMET (GORTEC…

Top Line: Does metastasis directed therapy improve progression free survival in oligometastatic breast cancer?The Study: Breast cancer would seem to…

Long-term follow-up of an early-adopted definitive treatment paradigm for oligometastatic non-small cell lung cancer that enrolled 45 patients between 2015…

Monotherapy. Despite the fact that “funding for de-escalation studies falls far short of that for systemic therapy escalation studies,” this…

Top Line: What happens if systemic therapy is deferred after SABR for oligometastatic disease?The Study: The SABR-5 study has provided…

It’s hard to keep up with the rapidly unfolding paradigm shifts in the management of oligometastatic non-small cell lung cancer…

Top Line: Does metastasis directed therapy reduce the risk of progression in men receiving intermittent ADT for oligometastatic prostate cancer?The…